Caerulein, a cholecystokinin-related peptide, depresses somatic function via the vagal afferent system.

[1]  T. Chase,et al.  Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy. , 1982, European journal of pharmacology.

[2]  W. Oldendorf,et al.  Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation , 1982, Brain Research.

[3]  K. Kawasaki,et al.  GABA-ergic influence on the crossed extensor reflex. , 1982, Life sciences.

[4]  G. Zetler.  Caerulfin and cholecystokinin octapeptide (CCK-8): Sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788 , 1982, Neuroscience Letters.

[5]  Y. Kudo,et al.  Excitation by lyoniol-A of vagal afferent nerves and the reflex autonomic and somatic actions in rats. , 1981, Journal of pharmacobio-dynamics.

[6]  F. Goodwin,et al.  Cholecystokinin reduces exploratory behavior in mice , 1981, Physiology & Behavior.

[7]  G. P. Smith,et al.  Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. , 1981, Science.

[8]  R. Innis,et al.  Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve. , 1981, Life sciences.

[9]  S. Paul,et al.  Vagotomy abolishes the inhibitory effects of cholecystokinin on rat exploratory behaviors , 1981 .

[10]  G. Zetler.  Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid , 1981, Neuroscience Letters.

[11]  K. Kawasaki,et al.  Sensitive depressant effect of benzodiazepines on the crossed extensor reflex in chloralose-anesthetized rats. , 1981, Life sciences.

[12]  G. Zetler.  Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol , 1981, Neuropharmacology.

[13]  C. Saper,et al.  Efferent connections of the parabrachial nucleus in the rat , 1980, Brain Research.

[14]  G. Zetler.  Anticonvulsant effects of careulein and cholecystokinin octapeptide, compared with those of diazepam. , 1980, European journal of pharmacology.

[15]  M. Ikeda,et al.  Reflectance of rat brain structures mapped by an optical fiber technique , 1980, Journal of Neuroscience Methods.

[16]  J. A. Ricardo,et al.  Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat , 1978, Brain Research.

[17]  C. Nemeroff,et al.  Cholecystokinin inhibits tail pinch-induced eating in rats. , 1978, Science.

[18]  K. Houpt,et al.  Satiety elicited by cholecystokinin in intact and vagotomized rats , 1977, Physiology & Behavior.

[19]  S. Shiozaki,et al.  Pharmacological studies of caerulein. II. The possibility of mediation through the central nervous system. , 1975, Japanese journal of pharmacology.

[20]  K. H. Ginzel.  Muscle relaxation by drugs which stimulate sensory nerve endings. I. The effect of veratrum alkaloids, phenyldiguanide and 5-hydroxytryptamine. , 1973, Neuropharmacology.

[21]  T. Kojima,et al.  Effects of caerulein on intestinal tract and gallbladder. , 1973, Japanese journal of pharmacology.

[22]  K. H. Ginzel.  Muscle relaxation by drugs which stimulate sensory nerve endings. II. The effect of nicotinic agents. , 1973, Neuropharmacology.

[23]  V. Erspamer,et al.  The actions of caerulein on the smooth muscle of the gastrointestinal tract and the gall bladder , 1968, British journal of pharmacology.